Cranford, New Jersey--(Newsfile Corp. - May 19, 2023) - WBB Research Institute (WBBRI) hosted a Demi-Colton Virtual Salon on the need for a global response to Candida auris and other deadly pathogens. Antimicrobial resistant C. auris is becoming a major public health threat and is found in over 30 countries causing outbreaks in hospitals, nursing homes, and other healthcare settings. It or another emerging antimicrobial resistant pathogen will likely be the cause of the next global pandemic. Scynexis (NASDAQ: SCYX) and T2 Biosystems (NASDAQ: TTOO) were two of the public companies that participated in the webinar, which highlighted the need for increased collaboration between academia, government agencies and the private sector to accelerate the development and use of rapid blood diagnostics and novel therapeutics.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Antimicrobial resistant C. auris is becoming a major public health threat
- The webinar highlighted the need for increased collaboration between academia, government agencies and the private sector.
- To accelerate the use of rapid from whole blood diagnostics and novel therapeutics.
Click image above to view full announcement.
WBB Securities
The WBB Research Institute is a research organization, founded by WBB Securities. The Institute focuses on emerging critical issues in healthcare that threaten to have profound impact. WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused on the life sciences. WBB Securities is registered with the SEC as a broker-dealer, a FINRA member firm, and a Registered Investment Advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.
Demy-Colton
Demy Colton is a leader in biotech and life science events, with over 20 years of experience connecting leaders of innovative biotech companies with key stakeholders, investors, and advisors, we create ideal environments to examine and address opportunities and challenges in today's biotech industry.www.demy-colton.com.
Contacts:
Fatima Bohorquez
(908) 518 7610
Fatima.Bohorquez@wbbsec.com
Source: WBB Securities
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/166755
